Back
Enlivex Therapeutics Ltd. 10K Form
Buy
54
ENLV
Enlivex Therapeutics Ltd.
Last Price:
$1.20
Seasonality Move:
5.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ENLV News And Ratings
See the #1 stock for the next 7 days that we like better than ENLV
ENLV Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-2.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.72 |
| Price / Book: | 1.61 |
Profitability
| EPS (TTM): | -0.53420 |
|---|---|
| Net Income (TTM): | $-12.7M |
| Gross Margin: | $-545K |
| Return on Equity: | -59.16% |
| Return on Assets: | -50.78% |
Enlivex Therapeutics Ltd. Earnings Forecast
Key Enlivex Therapeutics Ltd. Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 8 years.
Enlivex Therapeutics Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ENLV |
| CUSIP: | M4130Y |
| Website: | enlivex.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 6.43 |
| Quick Ratio: | 6.04 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ENLV Technical Analysis vs Fundamental Analysis
Buy
54
Enlivex Therapeutics Ltd. (ENLV)
is a Buy
Is Enlivex Therapeutics Ltd. a Buy or a Sell?
-
Enlivex Therapeutics Ltd. stock is rated a BuyThe current Enlivex Therapeutics Ltd. [ENLV] share price is $1.16. The Score for ENLV is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.